Clinical Trial Update: Treatment of Restless Legs Symptoms With Pramipexole to Improve the Outcomes of Protracted Opioid Withdrawal in OUD [Phase 2, Phase 3]

View source ↗

Summary

A Phase 2/3 trial evaluating pramipexole for restless legs symptoms to improve outcomes during protracted opioid withdrawal in opioid use disorder was terminate…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Opioid Use Disorder
• Opioid Withdrawal
• Restless Legs Syndrome
• Sleep Disorders

Drugs mentioned

• Pramipexole (pramipexole)

Snippet

Sponsor: Massachusetts General Hospital | Conditions: Sleep Disorder, Restless Legs Syndrome | Phase 2, Phase 3 | Status: TERMINATED | Results posted: 2025-09-22